Treatment of Hyperlipidemic States
Medical Clinics of North AmericaPublished 1 November 1970
E.H. Strisower, Gerald L. Adamson, Beverly Strisower
Citations16
SJR quartileQ1
SJR score1.52
SNIP2.00
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
A way to break the boredom in reading is choosing treatment of the hyperlipidemic states as the reading material.
Abstract
Sixteen type IIb and 26 type IIa hyperlipoproteinemic patients were treated with bezafibrate 200 mg t.i.d.. After 1 month VLDL-TG decreased by 54% in type IIb and by 43% in type IIa; LDL-C decreased by 13% in type IIb and by 23% in type IIa patients. HDL3-C rose in both group of patients, while HDL2-C significantly increased (52%) only in patients with phenotype IIb. The change in LDL-C and in HDL2-C concentrations resulted to be related to the pretreatment VLDL lipid concentration and to its change during the treatment.Twenty patients were treated with bezafibrate for 4 months. On the average, the changes in lipoprotein lipid concentration attained at the end of the first month of therapy remained substantially constant in the following 3 months.
Keywords
Medicine
New England Journal of MedicineFat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1,923 Citations1967Donald S. Fredrickson, Robert I. Levy +1 more
Annals of Internal MedicineFactors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience
1,798 Citations1961William B. Kannel, THOMAS R. DAWBER +3 more
Increasingly reliable estimates of the prevalence and incidence of coronary heart disease (CHD) emphasize the importance of this disease as a contemporary health hazard.
Annals of Internal MedicineEpidemiological Studies of Cardiovascular Disease in a Total Community—Tecumseh, Michigan
314 Citations1965Frederick H. Epstein, LEON D. OSTRANDER +5 more
This work presents a meta-analysis of data on prevalence, incidence, and mortality of coronary heart disease in Europe over a 25-year period from 1997 to 2002 that shows clear trends in prevalence and mortality.
CirculationCoronary Heart Disease among Minnesota Business and Professional Men Followed Fifteen Years
300 Citations1963Ancel Keys, Henry L. Taylor +4 more
Relative weight, body fatness, blood pressure, and serum cholesterol are reported from 281 Minnesota business and professional men, initially clinically healthy and aged 45 to 55, who were followed by annual examinations since the winter of 1947–48 to show a high degree of concordance.
Journal of Clinical InvestigationA comparison of heritable abnormal lipoprotein patterns as defined by two different techniques
225 Citations1968Donald S. Fredrickson, R. I. Levy +1 more
Eight plasma lipoprotein patterns currently employed in attempts to identify different forms of familial dyslipoproteinemia have been compared by two methods, indicating that lipop protein analyses obtained by either method may be used interconvertibly in further genetic and other clinical studies.
BMJCorn Oil in Treatment of Ischaemic Heart Disease
196 Citations1965G Rose, Wendy Thomson +1 more
(3) Absence of heart failure, and also of any non-cardiac disease likely to threaten life within two years, and of personal or geographical factors likely to interfere with clinic attendance or the taking of oil.
New England Journal of MedicineAcute Muscular Syndrome Associated with Administration of Clofibrate
191 Citations1968Terry Langer, Robert I. Levy
It is suggested that skeletal muscle is the major source of the elevated serum enzymes and that periodic examinations for evidence of muscle tenderness and dysfunction and frequent determinations of drug administration are needed.
The LancetCONTROLLED TRIAL OF A DIET HIGH IN UNSATURATED FAT FOR PREVENTION OF ATHEROSCLEROTIC COMPLICATIONS
166 Citations1968Seymour Dayton, MortonLee Pearce +7 more
The combined incidence of myocardial infarction, sudden death, and cerebralinfarction was significantly lower in the experimental group than in the control group, and total mortality-rates were similar for the two groups.
American Journal of Clinical NutritionDietary Prevention of Coronary Heart Disease: Long-Term Experiment
153 Citations1968Osmo Turpeinen, M Miettinen +5 more
American Journal of Public Health and the Nations HealthThe anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report.
142 Citations1966George Christakis, Seymour H. Rinzler +8 more
Experimental demonstration of the serum cholesterol-lowering effect of diets relatively rich in polyunsaturated fats supports the conviction that the study diet is responsible for the long-term depression of serum cholesterol observed in Anti-Coronary Club subjects.
The American Journal of MedicineHyperlipoproteinemia
115 Citations1954John W. Gofman, Leonard Rubin +2 more
The American Journal of CardiologyDiagnoses and management of hyperlipoproteinemia
111 Citations1968Robert I. Levy, Donald S. Fredrigkson
The American Journal of MedicineTreatment of hyperlipidemias
111 Citations1968E.H. Strisower, Gerald L. Adamson +1 more
It is suggested that if Sf 0–20 lipoproteins rise to high levels CPIB therapy should be discontinued, in view of the atherogenicity of S f 0– 20 lipoprotein concentrations, if CPIB treatment is discontinued.
Journal of the American Medical AssociationDIET IN CORONARY ATHEROSCLEROSIS
72 Citations1960Lester M. Morrison
A large-scale trial under controlled statistical conditions encountered in clinical practice is suggested for further evaluation of the role of fat in coronary atherosclerosis.
Archives of Internal MedicineHypertriglyceridemia, Diabetes Mellitus, and Coronary Vessel Disease
65 Citations1969Robert I. Levy
The clinical and chemical differentiation of hyperglyceridemia is discussed as are the roles of glucose intolerance, insulin response, dietary carbohydrate and fat, and obesity in each type ofHypertriglyceridemia.
Progress in Cardiovascular DiseasesCurrent status of the dietary prevention and treatment of atheroselerotic coronary heart disease
48 Citations1960Jeremiah Stamler
JAMAHyperglyceridemia in Coronary Artery Disease and Its Management
30 Citations1967Peter T. Kuo
Although time-consuming metabolic studies were required to clearly establish the nature of the basic disturbance, useful information could usually be obtained by serum lipoprotein analysis (paper electrophoresis) and serum lipid determinations (cholesterol, phospholipid, and triglyceride concentrations).
JAMAMedium-Chain Triglycerides
28 Citations1968Robert W. Harkins
A medium-chain triglyceride mixture (MCT) has recently become available, providing a special source of fat, containing triglycerides of octanoic and decanoic acids, C 8 and C 10 fatty acids, respectively, which may be useful in the nutritional management of subjects with impaired fat digestion or absorption.
CirculationThe Combined Use of CPIB and Thyroxine in Treatment of Hyperlipoproteinemias
17 Citations1966E.H. Strisower
In combined Sf 0–20 and Sf 20–105 hyperlipoproteinemias the combination of CPIB and thyroxine is often more effective than either agent used separately in reducing total lipoprotein concentrations.
JAMAClassification and Management of Familial Hyperlipoproteinemia
5 Citations1969Stanford Wessler
A 48-year-old white man was admitted to the Jewish Hospital for the second time on Feb 3, 1968, for evaluation of a rising serum cholesterol level, with a well-developed, well-nourished man in no distress.